Trial NCT00434226

View at ClinicalTrials.gov 
Org. Study IDs: AVF3996g

Last trial update was posted on 2009-08-21

MeSH Interventions

Bevacizumab Carboplatin Paclitaxel Sunitinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Small Cell Lung Cancer

Stopping Reasons

Based on data collected, the combination appeared to be poorly tolearated.

Limitations And Caveats

Based on the early safety results from this study, Genentech halted further recruitment and discontinued treatment. Insufficient efficacy data was available to perform additional analyses and limited the interpretation of the analyses performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID